Northern Trust Company of Connecticut’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
Other funds holding VRTX
BIT
Northern Trust Company of Connecticut's VRTX Position: Q4 2013 in Review
Northern Trust Company of Connecticut reduced its Vertex Pharmaceuticals (VRTX) stake by 0.45% in Q4 2013, selling an estimated $135K and leaving 428,002 shares worth $31.8M. The position accounts for 0.2% of the portfolio, ranked #107.
Northern Trust Company of Connecticut first reported a position in VRTX in Q2 2013 and has held it in 3 quarters since. The position peaked at $36.5M in Q2 2013. 387 funds tracked by Wall St. Rank hold VRTX as of Q4 2013.
- Northern Trust Company of Connecticut held 428,002 shares of Vertex Pharmaceuticals worth $31.8M as of Q4 2013.
- Northern Trust Company of Connecticut sold 1,933 Vertex Pharmaceuticals shares in Q4 2013, an estimated $135K.
- Vertex Pharmaceuticals made up 0.2% of Northern Trust Company of Connecticut's portfolio in Q4 2013, its #107 holding.
- Northern Trust Company of Connecticut first reported a position in Vertex Pharmaceuticals in Q2 2013 and has held it in 3 quarters since.
- Northern Trust Company of Connecticut's Vertex Pharmaceuticals position peaked at $36.5M in Q2 2013.
- 387 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q4 2013.
Based on Northern Trust Company of Connecticut's 13F filing for Q4 2013, filed 12 Feb 2014.